JP2022521973A5 - - Google Patents
Info
- Publication number
- JP2022521973A5 JP2022521973A5 JP2021549772A JP2021549772A JP2022521973A5 JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5 JP 2021549772 A JP2021549772 A JP 2021549772A JP 2021549772 A JP2021549772 A JP 2021549772A JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- alcam
- soluble
- composition according
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810628P | 2019-02-26 | 2019-02-26 | |
| US62/810,628 | 2019-02-26 | ||
| US201962933294P | 2019-11-08 | 2019-11-08 | |
| US62/933,294 | 2019-11-08 | ||
| PCT/US2020/019990 WO2020176682A1 (en) | 2019-02-26 | 2020-02-26 | Anti-cd6 antibody compositions and methods for treating lupus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521973A JP2022521973A (ja) | 2022-04-13 |
| JP2022521973A5 true JP2022521973A5 (cg-RX-API-DMAC7.html) | 2023-03-02 |
Family
ID=70009403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549772A Ceased JP2022521973A (ja) | 2019-02-26 | 2020-02-26 | 抗cd6抗体組成物およびループスを処置するための方法 |
Country Status (12)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2993186T (pt) | 2008-03-14 | 2019-11-29 | Biocon Ltd | Anticorpo monoclonal e um método do mesmo |
| IL303290A (en) * | 2020-12-04 | 2023-07-01 | Equillium Inc | Methods of selectively targeting cd6 high cells and decreasing activity of t eff cells |
| EP4533094A4 (en) * | 2022-05-25 | 2026-05-06 | Univ Houston System | METHODS AND SYSTEMS FOR RISK STRATIFICATION AND BLADDER CANCER MANAGEMENT |
| TWI869873B (zh) * | 2023-06-05 | 2025-01-11 | 中國醫藥大學 | 一種檢測一個體罹患單純復發性風濕病的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5998172A (en) * | 1993-11-02 | 1999-12-07 | Duke University | Anti-CD6 ligand antibodies |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| CU22584A1 (es) | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| AU747898B2 (en) * | 1997-03-03 | 2002-05-30 | Bristol-Myers Squibb Company | Monoclonal antibodies to human CD6 |
| MY154819A (en) | 2006-12-26 | 2015-07-31 | Centro Inmunologia Molecular | Pharmaceutical compositions with capacity to induce adoptosis in tumor cells for the diagnosis and treatment of the b-cell chroniclymphocytic leukemia |
| PT2993186T (pt) * | 2008-03-14 | 2019-11-29 | Biocon Ltd | Anticorpo monoclonal e um método do mesmo |
| WO2012133047A1 (ja) * | 2011-03-25 | 2012-10-04 | コニカミノルタエムジー株式会社 | 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法 |
| EP2726879B1 (en) * | 2011-07-01 | 2022-10-19 | Beckman Coulter, Inc. | Requlatory t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 |
| CA2866612C (en) * | 2012-03-08 | 2018-01-16 | Halozyme, Inc. | Conditionally active ph-dependent cetuximab variant anti-epidermal growth factor receptor antibodies and method of use thereof |
| US10620201B2 (en) * | 2014-01-20 | 2020-04-14 | Pad 4 Di Maria Adele Silvia Denegri S.A.S. | In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis |
| SG11201808625QA (en) * | 2016-04-04 | 2018-10-30 | Chemocentryx Inc | SOLUBLE C5aR ANTAGONISTS |
| WO2017214452A1 (en) * | 2016-06-08 | 2017-12-14 | Xencor, Inc. | Treatment of igg4-related diseases with anti-cd19 antibodies crossbinding to cd32b |
| KR102514528B1 (ko) * | 2016-10-21 | 2023-03-27 | 바이오콘 리미티드 | 루푸스 치료를 위한 단일클론항체 및 이의 치료방법 |
-
2020
- 2020-02-26 WO PCT/US2020/019990 patent/WO2020176682A1/en not_active Ceased
- 2020-02-26 AU AU2020229830A patent/AU2020229830A1/en active Pending
- 2020-02-26 CN CN202080016831.1A patent/CN113490511B/zh active Active
- 2020-02-26 BR BR112021016967A patent/BR112021016967A2/pt unknown
- 2020-02-26 SG SG11202109118XA patent/SG11202109118XA/en unknown
- 2020-02-26 US US17/434,247 patent/US20220143140A1/en not_active Abandoned
- 2020-02-26 EP EP20714769.5A patent/EP3930751A1/en active Pending
- 2020-02-26 PH PH1/2021/551994A patent/PH12021551994A1/en unknown
- 2020-02-26 JP JP2021549772A patent/JP2022521973A/ja not_active Ceased
- 2020-02-26 CA CA3131299A patent/CA3131299A1/en active Pending
- 2020-02-26 MX MX2021010283A patent/MX2021010283A/es unknown
-
2021
- 2021-09-22 ZA ZA2021/07077A patent/ZA202107077B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10822403B2 (en) | Composition and method for the diagnosis and treatment of iron-related disorders | |
| RU2636345C2 (ru) | Новое антитело к cxcr4 и его применение для выявления и диагностики рака | |
| JP6138780B2 (ja) | 癌の検出および診断のための抗体i−3859の使用 | |
| CA3091801A1 (en) | B7-h4 antibodies and methods of use thereof | |
| HUE030578T2 (en) | Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation | |
| EP3589652B1 (en) | Recombinant antibodies to programmed death 1 (pd-1) and uses therefor | |
| CN113490511B (zh) | 用于治疗狼疮的抗cd6抗体组合物和方法 | |
| CN114650866B (zh) | 新的用于诊断的分子 | |
| US20230287512A1 (en) | Marker for response to pd-1/pd-l1 immunotherapy | |
| KR20190130506A (ko) | 골수유래억제세포 관련 질환의 예방 및 치료 용도 | |
| JP2025533015A (ja) | 薬物抵抗性肝細胞癌の処置 | |
| EP4471057A1 (en) | Anti-human cxcl1 antibody | |
| US11009507B2 (en) | Methods and diagnostics for cancer detection and treatment monitoring | |
| KR20180118151A (ko) | 다발성 골수종에서 m-단백질 반응의 임상 평가 | |
| JP7300687B2 (ja) | 肝細胞癌診断用バイオマーカーセレブロンと、これに特異的な新規なモノクローナル抗体 | |
| US20230093265A1 (en) | New method and compound for prostate cancer diagnosis | |
| TWI869740B (zh) | 一種體外檢測sTNFR2蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| CN110596369A (zh) | 一种用于检测人tim-3表达水平的试剂盒 | |
| CN110891604B (zh) | 靶向人TAXILINα的单克隆抗体及其使用方法 | |
| US10823735B2 (en) | Monoclonal antibody for predicting tamoxifen response in breast cancer patients | |
| JP4851620B2 (ja) | Nk4に対するモノクローナル抗体 | |
| CN118684779A (zh) | 一种抗Trop2单克隆抗体药物或其衍生物的特异性结合剂及其应用 | |
| CN116710575A (zh) | 对pd-1/pd-l1免疫疗法有反应的标志物 | |
| NZ749138A (en) | Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer | |
| NZ749138B2 (en) | Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer |